Strides Pharma Science OTC
FDA Approved Drugs

Strides Pharma Science OTC

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

OTC
  • Total Records 6
  • Latest Approval Date Feb 22, 2021
  • Data Source FDA
  • First Approval Date Aug 14, 2006
All
227
View
Unclassified
1
View
Discontinued
103
View
OTC
6
View
RX
117
View
Company Overview

Company

Strides Pharma Science OTC

Country

India

Social Profiles

LinkedIn
Company Snapshot

Strides Pharma Science OTC

Strides House, Bilekahalli, Bannerghatta Road, Bangalore – 560076

India

www.synergice.co/ enquiries@synergice.co View on Map
FDA Approved Drug Records ( 6 records )
2011
28 Mar
OTC Application: 79129

Drug Name

IBUPROFEN

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2011-03-28

79129 / 1

Active Ingredient

IBUPROFEN

Application Number

79129

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2011-03-28

Regulatory Status

OTC

2011
04 Apr
OTC Application: 91355

Drug Name

IBUPROFEN

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2011-04-04

91355 / 1

Active Ingredient

IBUPROFEN

Application Number

91355

Product Number

1

Dosage Form

-

Strength

200MG

Approval Date

2011-04-04

Regulatory Status

OTC

2021
22 Feb
OTC Application: 211666

Drug Name

IBUPROFEN

Product Number

1

Dosage Form

-

Strength

100MG/5ML

Approval Date

2021-02-22

211666 / 1

Active Ingredient

IBUPROFEN

Application Number

211666

Product Number

1

Dosage Form

-

Strength

100MG/5ML

Approval Date

2021-02-22

Regulatory Status

OTC

2006
14 Aug
OTC Application: 77628

Drug Name

IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

200MG;30MG

Approval Date

2006-08-14

77628 / 1

Active Ingredient

IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE

Application Number

77628

Product Number

1

Dosage Form

-

Strength

200MG;30MG

Approval Date

2006-08-14

Regulatory Status

OTC

2016
24 Aug
OTC Application: 203928

Drug Name

POLYETHYLENE GLYCOL 3350

Product Number

1

Dosage Form

-

Strength

17GM/SCOOPFUL

Approval Date

2016-08-24

203928 / 1

Active Ingredient

POLYETHYLENE GLYCOL 3350

Application Number

203928

Product Number

1

Dosage Form

-

Strength

17GM/SCOOPFUL

Approval Date

2016-08-24

Regulatory Status

OTC

2016
24 Aug
OTC Application: 203928

Drug Name

POLYETHYLENE GLYCOL 3350

Product Number

2

Dosage Form

-

Strength

17GM/PACKET

Approval Date

2016-08-24

203928 / 2

Active Ingredient

POLYETHYLENE GLYCOL 3350

Application Number

203928

Product Number

2

Dosage Form

-

Strength

17GM/PACKET

Approval Date

2016-08-24

Regulatory Status

OTC

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    1 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    227 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
6 total
  • OTC
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

IBUPROFEN

Application Number

79129

Product Number

1

Active Ingredient

IBUPROFEN

Dosage Form

-

Strength

200MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.